Literature DB >> 33244865

Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.

Dongwei Dou1, Xiaoyang Ren2, Mingli Han1, Xiaodong Xu1, Xin Ge1, Yuanting Gu1, Xinxing Wang1, Song Zhao3.   

Abstract

Circular RNAs (circRNAs) have been shown to modulate gene expression and participate in the development of multiple malignancies. The purpose of this study was to investigate the role of circ_0008039 in breast cancer (BC). The expression of circ_0008039, miR-140-3p, and spindle and kinetochore-associated protein 2 (SKA2) was detected by qRT-PCR. Cell viability, colony formation, migration, and invasion were evaluated using methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, colony formation assay, and transwell assay, respectively. Glucose consumption and lactate production were measured using commercial kits. Protein levels of hexokinase II (HK2) and SKA2 were determined by western blot. The interaction between miR-140-3p and circ_0008039 or SKA2 was verified by dual-luciferase reporter assay. Finally, a mouse xenograft model was established to investigate the roles of circ_0008039 in BC in vivo. We found that circ_0008039 and SKA2 were upregulated in BC tissues and cells, while miR-140-3p was downregulated. Knockdown of circ_0008039 suppressed BC cell proliferation, migration, invasion, and glycolysis. Moreover, miR-140-3p could bind to circ_0008039 and its inhibition reversed the inhibitory effect of circ_0008039 interference on proliferation, migration, invasion, and glycolysis in BC cells. SKA2 was verified as a direct target of miR-140-3p and its overexpression partially inhibited the suppressive effect of miR-140-3p restoration in BC cells. Additionally, circ_0008039 positively regulated SKA2 expression by sponging miR-140-3p. Consistently, silencing circ_0008039 restrained tumor growth via increasing miR-140-3p and decreasing SKA2. In conclusion, circ_0008039 downregulation suppressed BC cell proliferation, migration, invasion, and glycolysis partially through regulating the miR-140-3p/SKA2 axis, providing an important theoretical basis for treatment of BC.
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

Entities:  

Keywords:  SKA2; breast cancer; circ_0008039; miR-140-3p

Mesh:

Substances:

Year:  2020        PMID: 33244865      PMCID: PMC7858101          DOI: 10.1002/1878-0261.12862

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   7.449


  28 in total

1.  Long non-coding RNA SPRY4-IT1 promotes the proliferation and invasion of U251 cells through upregulation of SKA2.

Authors:  Xiao-Jun He; Er-Bao Bian; Chun-Chun Ma; Chao Wang; Hong-Liang Wang; Bing Zhao
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

2.  Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis.

Authors:  Yanhua Liu; Cuntao Lu; Yizhou Zhou; Zhihong Zhang; Li Sun
Journal:  Biochem Biophys Res Commun       Date:  2018-05-31       Impact factor: 3.575

3.  Upregulation of microRNA-520a-3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer.

Authors:  Hui Su; Feng Ren; Haitao Jiang; Yunjie Chen; Xiaoxiang Fan
Journal:  Oncol Lett       Date:  2019-07-25       Impact factor: 2.967

4.  MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression.

Authors:  Zhouhui Ren; Tong Yang; Jie Ding; Weihong Liu; Xiangyu Meng; Pingping Zhang; Kaitai Liu; Ping Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 5.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

Review 6.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

7.  Identifying microRNA/mRNA dysregulations in ovarian cancer.

Authors:  Gregory D Miles; Michael Seiler; Lorna Rodriguez; Gunaretnam Rajagopal; Gyan Bhanot
Journal:  BMC Res Notes       Date:  2012-03-27

8.  circBase: a database for circular RNAs.

Authors:  Petar Glažar; Panagiotis Papavasileiou; Nikolaus Rajewsky
Journal:  RNA       Date:  2014-09-18       Impact factor: 4.942

9.  The PRR11-SKA2 Bidirectional Transcription Unit Is Negatively Regulated by p53 through NF-Y in Lung Cancer Cells.

Authors:  Yitao Wang; Huali Weng; Ying Zhang; Yinjiang Long; Yi Li; Yulong Niu; Fangzhou Song; Youquan Bu
Journal:  Int J Mol Sci       Date:  2017-03-01       Impact factor: 5.923

10.  A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.

Authors:  Huai-Qiang Ju; Qi Zhao; Feng Wang; Ping Lan; Zixian Wang; Zhi-Xiang Zuo; Qi-Nian Wu; Xin-Juan Fan; Hai-Yu Mo; Li Chen; Ting Li; Chao Ren; Xiang-Bo Wan; Gong Chen; Yu-Hong Li; Wei-Hua Jia; Rui-Hua Xu
Journal:  EMBO Mol Med       Date:  2019-09-02       Impact factor: 12.137

View more
  10 in total

1.  Characterization of the microRNA transcriptomes and proteomics of cochlear tissue-derived small extracellular vesicles from mice of different ages after birth.

Authors:  Pei Jiang; Xiangyu Ma; Shanying Han; Leyao Ma; Jingru Ai; Leilei Wu; Yuan Zhang; Hairong Xiao; Mengyao Tian; W Andy Tao; Shasha Zhang; Renjie Chai
Journal:  Cell Mol Life Sci       Date:  2022-02-26       Impact factor: 9.261

Review 2.  Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.

Authors:  Mitra Behroozaghdam; Maryam Dehghani; Amirhossein Zabolian; Davood Kamali; Salar Javanshir; Farzaneh Hasani Sadi; Mehrdad Hashemi; Teimour Tabari; Mohsen Rashidi; Sepideh Mirzaei; Atefeh Zarepour; Ali Zarrabi; Danielle De Greef; Anupam Bishayee
Journal:  Cell Mol Life Sci       Date:  2022-10-04       Impact factor: 9.207

Review 3.  LncRNAs and CircRNAs in cancer.

Authors:  Xin Yin; Huiran Lin; Lei Lin; Lei Miao; Jing He; Zhenjian Zhuo
Journal:  MedComm (2020)       Date:  2022-05-12

4.  Circ0001470 Acts as a miR-140-3p Sponge to Facilitate the Progression of Embryonic Development through Regulating PTGFR Expression.

Authors:  Long Zhang; Changfan Zhou; Xiaoyu Jiang; Shuntao Huang; Yiheng Li; Tao Su; Guowei Wang; You Zhou; Min Liu; Dequan Xu
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

5.  Spindle and kinetochore-associated complex subunit 3 (SKA3) promotes stem cell-like properties of hepatocellular carcinoma cells through activating Notch signaling pathway.

Authors:  Shuya Bai; Wei Chen; Mengli Zheng; Xiju Wang; Wang Peng; Yuchong Zhao; Yun Wang; Si Xiong; Bin Cheng
Journal:  Ann Transl Med       Date:  2021-09

6.  Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.

Authors:  Jianfeng Ding; Xiaobo He; Jinkun Wang; Guodong Cao; Sihan Chen; Liping Yuan; Bo Chen; Maoming Xiong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.

Authors:  Janusz Matuszyk
Journal:  Mol Med       Date:  2022-08-03       Impact factor: 6.376

8.  Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p.

Authors:  Dan-Dan Zhu; Xin-Bo Yu; Wen Jiang; Yu Zhu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

9.  Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma.

Authors:  Yabin Sun; Xinmin Zhang; Zhongyi Cong; Siying Teng
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

10.  Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation.

Authors:  Hong Lin; Fangyi Long; Xiqian Zhang; Pinghan Wang; Ting Wang
Journal:  Front Mol Biosci       Date:  2022-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.